Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

End-stage kidney disease (ESKD) is the most severe form of chronic kidney disease with patients usually requiring kidney replacement therapy in the form of dialysis or kidney transplantation to survive. Projections of the prevalence of treated end-stage kidney disease in Australia presents national level projections of the number of people receiving kidney replacement therapy for their ESKD for the period 2012 to 2020. This information is important for predicting the future burden of ESKD in Australia.

ISBN: 978-1-74249-578-1

Cat. no: PHE 176

Pages: 59

Findings from this report:

In 2020, almost half (48%) of treated-ESKD patients are predicted to have a kidney transplant, 73% increase from 2011

The number of people receiving Kidney Replacement Therapy (KRT) for ESKD tripled between 1991 and 2011

The prevalence of treated ESKD is projected to rise by between 45 and 64% between 2011 and 2020

The prevalence is projected to double for those who start treatment when they are over 75 years